Home » Advaxis India Cervix Cancer Trial Begins Dosing
Advaxis India Cervix Cancer Trial Begins Dosing
Advaxis, Inc. … has begun dosing patients in its 110 patient clinical trial of ADXS11-001 for the treatment of cervix cancer in women for whom cytotoxic treatment has failed.
StreetInsider
StreetInsider
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct